Hip & pelvis

The Korean Hip Society (대한고관절학회)
권호 표지
DOI QR코드

DOI QR Code

Updating Osteonecrosis of the Femoral Head

  • Young-Seung Ko (Department of Orthopaedic Surgery, Seoul National University Bundang Hospital) ;
  • Joo Hyung Ha (Department of Orthopaedic Surgery, Gumdan Top General Hospital) ;
  • Jung-Wee Park (Department of Orthopaedic Surgery, Seoul National University Bundang Hospital) ;
  • Young-Kyun Lee (Department of Orthopaedic Surgery, Seoul National University Bundang Hospital) ;
  • Tae-Young Kim (Department of Orthopaedic Surgery, Konkuk University Medical Center, Konkuk University School of Medicine) ;
  • Kyung-Hoi Koo (Department of Orthopaedic Surgery, Seoul National University Bundang Hospital)
  • Received : 2023.01.27
  • Accepted : 2023.06.16
  • Published : 2023.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Osteonecrosis of the femoral head (ONFH), a condition characterized by the presence of a necrotic bone lesion in the femoral head, is caused by a disruption in the blood supply. Its occurrence is more common in young and middle-aged adults and it is the main reason for performance of total hip arthroplasty in this age group. Its incidence is increasing along with increased use of glucocorticoids for management of adjuvant therapy for treatment of leukemia as well as organ transplantation and other myelogenous diseases. Current information on etiology and pathogenesis, as well as natural history, stage system, and treatments is provided in this review. A description of the Association Research Circulation Osseous (ARCO) criteria for classification of glucocorticoids-and alcohol-associated ONFH, 2019 ARCO staging system, and 2021 ARCO classification using computed tomography for the early stages of ONFH is also provided.

Keywords

References

  1. Arlet J. Nontraumatic avascular necrosis of the femoral head. Past, present, and future. Clin Orthop Relat Res. 1992;(277):12-21. 
  2. Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg Am. 2015;97:1604-27. https://doi.org/10.2106/JBJS.O.00071 
  3. Park JW, Won SH, Moon SY, Lee YK, Ha YC, Koo KH. Burden and future projection of revision Total hip Arthroplasty in South Korea. BMC Musculoskelet Disord. 2021;22:375. https://doi.org/10.1186/s12891-021-04235-3 
  4. van der Jagt D, Mokete L, Pietrzak J, Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2015;23:69-70. https://doi.org/10.5435/JAAOS-D-14-00431 
  5. Yamaguchi R, Yamamoto T, Motomura G, Ikemura S, Iwamoto Y. Incidence of nontraumatic osteonecrosis of the femoral head in the Japanese population. Arthritis Rheum. 2011;63:3169-73. https://doi.org/10.1002/art.30484 
  6. Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015;6:590-601. https://doi.org/10.5312/wjo.v6.i8.590 
  7. Kang JS, Park S, Song JH, Jung YY, Cho MR, Rhyu KH. Prevalence of osteonecrosis of the femoral head: a nationwide epidemiologic analysis in Korea. J Arthroplasty. 2009;24:1178-83. https://doi.org/10.1016/j.arth.2009.05.022 
  8. Park JW, Kim HS, Park S, Kim SH, Lee YK, Koo KH. Trends in surgical treatment of femoral head osteonecrosis in South Korea: an analysis using nationwide claims database. Clin Orthop Surg. 2022;14:500-6. https://doi.org/10.4055/cios22027 
  9. Cui Q, Jo WL, Koo KH, et al. ARCO consensus on the pathogenesis of non-traumatic osteonecrosis of the femoral head. J Korean Med Sci. 2021;36:e65. https://doi.org/10.3346/jkms.2021.36.e65 
  10. Yoon BH, Jones LC, Chen CH, et al. Etiologic classification criteria of ARCO on femoral head osteonecrosis part 1: glucocorticoid-associated osteonecrosis. J Arthroplasty. 2019;34:163-8.e1. https://doi.org/10.1016/j.arth.2018.09.005 
  11. Yoon BH, Jones LC, Chen CH, et al. Etiologic classification criteria of ARCO on femoral head osteonecrosis part 2: alcohol-associated osteonecrosis. J Arthroplasty. 2019;34:169-74.e1. https://doi.org/10.1016/j.arth.2018.09.006 
  12. Seamon J, Keller T, Saleh J, Cui Q. The pathogenesis of nontraumatic osteonecrosis. Arthritis. 2012;2012:601763. https://doi.org/10.1155/2012/601763 
  13. Mont MA, Salem HS, Piuzzi NS, Goodman SB, Jones LC. Nontraumatic osteonecrosis of the femoral head: where do we stand today?: a 5-year update. J Bone Joint Surg Am. 2020;102:1084-99. https://doi.org/10.2106/JBJS.19.01271 
  14. Ikeuchi K, Hasegawa Y, Seki T, Takegami Y, Amano T, Ishiguro N. Epidemiology of nontraumatic osteonecrosis of the femoral head in Japan. Mod Rheumatol. 2015;25:278-81. https://doi.org/10.3109/14397595.2014.932038 
  15. Karantanas AH. Accuracy and limitations of diagnostic methods for avascular necrosis of the hip. Expert Opin Med Diagn. 2013;7:179-87. https://doi.org/10.1517/17530059.2013.757592 
  16. Ha YC, Jung WH, Kim JR, Seong NH, Kim SY, Koo KH. Prediction of collapse in femoral head osteonecrosis: a modified Kerboul method with use of magnetic resonance images. J Bone Joint Surg Am. 2006;88 Suppl 3:35-40. https://doi.org/10.2106/JBJS.F.00535 
  17. Kim YM, Ahn JH, Kang HS, Kim HJ. Estimation of the extent of osteonecrosis of the femoral head using MRI. J Bone Joint Surg Br. 1998;80:954-8. https://doi.org/10.1302/0301-620x.80b6.8309 
  18. Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci. 2002;7:601-5. https://doi.org/10.1007/s007760200108 
  19. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br. 1995;77:34-41. https://doi.org/10.1302/0301-620X.77B1.7822393 
  20. Lee YJ, Cui Q, Koo KH. Is there a role of pharmacological treatments in the prevention or treatment of osteonecrosis of the femoral head?: a systematic review. J Bone Metab. 2019;26:13-8. https://doi.org/10.11005/jbm.2019.26.1.13 
  21. Hines JT, Jo WL, Cui Q, et al. Osteonecrosis of the femoral head: an updated review of ARCO on pathogenesis, staging and treatment. J Korean Med Sci. 2021;36:e177. https://doi.org/10.3346/jkms.2021.36.e177 
  22. Lee YK, Lee B, Parvizi J, Ha YC, Koo KH. Which osteotomy for osteonecrosis of the femoral head and which patient for the osteotomy? Clin Orthop Surg. 2019;11:137-41. https://doi.org/10.4055/cios.2019.11.2.137 
  23. Dale T. Bone necrosis in divers; caisson disease. Acta Chir Scand. 1952;104:153-6. 
  24. Ravault PP, Lejeune E, Colomb D, Fries D. [Osteonecrosis of the femur head associated with corticotherapy]. Rev Rhum Mal Osteoartic. 1962;29:546-50. French. 
  25. Chung SM, Ralston EL. Necrosis of the femoral head associated with sickle-cell anemia and its genetic variants. A review of the literature and study of thirteen cases. J Bone Joint Surg Am. 1969;51:33-58. 
  26. Arlet J, Franck JL, Nghiem L, Solera ML, de Graeve J.[Multiple bone necroses and familial type I hyperlipemia. Apropos of a case report]. Rev Rhum Mal Osteoartic. 1983;50:149-53. French. 
  27. Pierre-Jacques H, Glueck CJ, Mont MA, Hungerford DS. Familial heterozygous protein-S deficiency in a patient who had multifocal osteonecrosis. A case report. J Bone Joint Surg Am. 1997;79:1079-84. https://doi.org/10.2106/00004623-199707000-00017 
  28. Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Clin Orthop Relat Res. 1997;(334):43-56. 
  29. Jones LC, Mont MA, Le TB, et al. Procoagulants and osteonecrosis. J Rheumatol. 2003;30:783-91. 
  30. Zalavras CG, Vartholomatos G, Dokou E, Malizos KN. Genetic background of osteonecrosis: associated with thrombophilic mutations? Clin Orthop Relat Res. 2004;(422):251-5. 
  31. Korompilias AV, Gilkeson GS, Ortel TL, Seaber AV, Urbaniak JR. Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop Relat Res. 1997;(345):174-80. 
  32. Seleznick MJ, Silveira LH, Espinoza LR. Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol. 1991;18:1416-7. 
  33. Bjorkman A, Svensson PJ, Hillarp A, Burtscher IM, Runow A, Benoni G. Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop Relat Res. 2004;(425):168-72. 
  34. Glueck CJ, Fontaine RN, Gruppo R, et al. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop Relat Res. 1999;(366):133-46. https://doi.org/10.1097/00003086-199909000-00017 
  35. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res. 2001;(386):19-33. https://doi.org/10.1097/00003086-200105000-00004 
  36. Glueck CJ, Freiberg RA, Boppana S, Wang P. Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis. J Bone Joint Surg Am. 2008;90:2220-9. https://doi.org/10.2106/JBJS.G.00616 
  37. Kim T, Hong JM, Lee J, et al. Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population. Osteoarthritis Cartilage. 2008;16:287-91. https://doi.org/10.1016/j.joca.2007.06.017 
  38. Koo KH, Lee JS, Lee YJ, Kim KJ, Yoo JJ, Kim HJ. Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis. J Orthop Res. 2006;24:1722-8. https://doi.org/10.1002/jor.20164 
  39. Lee YJ, Lee JS, Kang EH, et al. Vascular endothelial growth factor polymorphisms in patients with steroid-induced femoral head osteonecrosis. J Orthop Res. 2012;30:21-7. https://doi.org/10.1002/jor.21492 
  40. Koo KH, Mont MA, Jones LC. Osteonecrosis. Springer Berlin; 2014. 59-139. 
  41. Koo KH, Jeong ST, Jones JP Jr. Borderline necrosis of the femoral head. Clin Orthop Relat Res. 1999;(358):158-65. 
  42. Cui Q, Wang GJ, Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J Bone Joint Surg Am. 1997;79:1054-63. https://doi.org/10.2106/00004623-199707000-00012 
  43. Cui Q, Wang Y, Saleh KJ, Wang GJ, Balian G. Alcohol-induced adipogenesis in a cloned bone-marrow stem cell. J Bone Joint Surg Am. 2006;88 Suppl 3:148-54. https://doi.org/10.2106/JBJS.F.00534 
  44. Wang GJ, Sweet DE, Reger SI, Thompson RC. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am. 1977;59:729-35. 
  45. Koo KH, Ahn IO, Kim R, et al. Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images. Radiology. 1999;213:715-22. https://doi.org/10.1148/radiology.213.3.r99dc06715 
  46. Yoon BH, Mont MA, Koo KH, et al. The 2019 revised version of Association Research Circulation Osseous staging system of osteonecrosis of the femoral head. J Arthroplasty. 2020;35:933-40. https://doi.org/10.1016/j.arth.2019.11.029 
  47. Koo KH, Mont MA, Cui Q, et al. The 2021 Association Research Circulation Osseous classification for early-stage osteonecrosis of the femoral head to computed tomography-based study. J Arthroplasty. 2022;37:1074-82. https://doi.org/10.1016/j.arth.2022.02.009 
  48. Ajmal M, Matas AJ, Kuskowski M, Cheng EY. Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am. 2009;40:235-9. https://doi.org/10.1016/j.ocl.2009.01.004 
  49. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;(435):164-70. https://doi.org/10.1097/01.blo.0000157539.67567.03 
  50. Glueck CJ, Freiberg RA, Wissman R, Wang P. Long term anticoagulation (4-16 years) stops progression of idiopathic hip osteonecrosis associated with familial thrombophilia. Adv Orthop. 2015;2015:138382. https://doi.org/10.1155/2015/138382 
  51. Pengde K, Fuxing P, Bin S, Jing Y, Jingqiu C. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine. 2008;75:696-701. https://doi.org/10.1016/j.jbspin.2007.12.008 
  52. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001;(386):173-8. https://doi.org/10.1097/00003086-200105000-00022 
  53. Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. 2005;87:2155-9. 
  54. Lee YK, Ha YC, Cho YJ, et al. Does zoledronate prevent femoral head collapse from osteonecrosis? A prospective, randomized, open-label, multicenter study. J Bone Joint Surg Am. 2015;97:1142-8. https://doi.org/10.2106/JBJS.N.01157 
  55. Yoon BH, Lee YK, Kim KC, Ha YC, Koo KH. No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis. Int Orthop. 2018;42:2737-43. https://doi.org/10.1007/s00264-018-3977-9 
  56. Hernigou P, Dubory A, Homma Y, et al. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018;42:1639-49. https://doi.org/10.1007/s00264-018-3941-8 
  57. Kang JS, Suh YJ, Moon KH, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression. Stem Cell Res Ther. 2018;9:274. https://doi.org/10.1186/s13287-018-1030-y 
  58. Li X, Xu X, Wu W. Comparison of bone marrow mesenchymal stem cells and core decompression in treatment of osteonecrosis of the femoral head: a meta-analysis. Int J Clin Exp Pathol. 2014;7:5024-30. 
  59. Ma Y, Wang T, Liao J, et al. Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head: a prospective, double-blinded, randomized, controlled study. Stem Cell Res Ther. 2014;5:115. https://doi.org/10.1186/scrt505 
  60. Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty. 2012;27:679-86. https://doi.org/10.1016/j.arth.2011.08.008 
  61. Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50:325-30. https://doi.org/10.1016/j.bone.2011.11.002 
  62. Lim YW, Kim YS, Lee JW, Kwon SY. Stem cell implantation for osteonecrosis of the femoral head. Exp Mol Med. 2013;45:e61. https://doi.org/10.1038/emm.2013.128 
  63. Nally FJ, Zanotti G, Buttaro MA, et al. THA conversion rate comparing decompression alone, with autologous bone graft or stem cells in osteonecrosis. Hip Int. 2018;28:189-93. https://doi.org/10.5301/hipint.5000552 Erratum in: Hip Int. 2020;1120700020941333. https://doi.org/10.1177/1120700020941333 
  64. Pepke W, Kasten P, Beckmann NA, Janicki P, Egermann M. Core decompression and autologous bone marrow concentrate for treatment of femoral head osteonecrosis: a randomized prospective study. Orthop Rev (Pavia). 2016;8:6162. https://doi.org/10.4081/or.2016.6162 
  65. Ha YC, Kim HJ, Kim SY, Kim KC, Lee YK, Koo KH. Effects of age and body mass index on the results of transtrochanteric rotational osteotomy for femoral head osteonecrosis. J Bone Joint Surg Am. 2010;92:314-21. https://doi.org/10.2106/JBJS.H.01020 
  66. Sugioka Y. Transtrochanteric anterior rotational osteotomy of the femoral head in the treatment of osteonecrosis affecting the hip: a new osteotomy operation. Clin Orthop Relat Res. 1978;(130):191-201. 
  67. Lee YK, Park CH, Ha YC, Kim DY, Lyu SH, Koo KH. Comparison of surgical parameters and results between curved varus osteotomy and rotational osteotomy for osteonecrosis of the femoral head. Clin Orthop Surg. 2017;9:160-8. https://doi.org/10.4055/cios.2017.9.2.160 
  68. Judet J, Judet H, Gilbert A. [Trial revascularization of the femur head with a pediculed fibular transplant]. Rev Chir Orthop Reparatrice Appar Mot. 1980;66 Suppl 2:65. French. 
  69. Urbaniak JR, Coogan PG, Gunneson EB, Nunley JA. Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting. A long-term follow-up study of one hundred and three hips. J Bone Joint Surg Am. 1995;77:681-94. https://doi.org/10.2106/00004623-199505000-00004 
  70. Yoo MC, Chung DW, Hahn CS. Free vascularized fibula grafting for the treatment of osteonecrosis of the femoral head. Clin Orthop Relat Res. 1992;(277):128-38. 
  71. Zhao D, Xu D, Wang W, Cui X. Iliac graft vascularization for femoral head osteonecrosis. Clin Orthop Relat Res. 2006;442:171-9. https://doi.org/10.1097/01.blo.0000181490.31424.96 
  72. Amstutz HC, Le Duff MJ. Current status of hemi-resurfacing arthroplasty for osteonecrosis of the hip: a 27-year experience. Orthop Clin North Am. 2009;40:275-82. https://doi.org/10.1016/j.ocl.2008.12.001 
  73. De Smet KA, Van Der Straeten C, Van Orsouw M, Doubi R, Backers K, Grammatopoulos G. Revisions of metal-on-metal hip resurfacing: lessons learned and improved outcome. Orthop Clin North Am. 2011;42:259-69, ix. https://doi.org/10.1016/j.ocl.2011.01.003 
  74. Zustin J, Sauter G, Morlock MM, Ruther W, Amling M. Association of osteonecrosis and failure of hip resurfacing arthroplasty. Clin Orthop Relat Res. 2010;468:756-61. https://doi.org/10.1007/s11999-009-0979-3 
  75. Junnila M, Seppanen M, Mokka J, et al. Adverse reaction to metal debris after Birmingham Hip Resurfacing arthroplasty. Acta Orthop. 2015;86:345-50. https://doi.org/10.3109/17453674.2014.1004015 
  76. Matharu GS, Berryman F, Judge A, et al. Blood metal ion thresholds to identify patients with metal-on-metal hip implants at risk of adverse reactions to metal debris: an external multicenter validation study of Birmingham Hip Resurfacing and Corail-Pinnacle implants. J Bone Joint Surg Am. 2017;99:1532-9. https://doi.org/10.2106/JBJS.16.01568 
  77. Kamath AF, Prieto H, Lewallen DG. Alternative bearings in total hip arthroplasty in the young patient. Orthop Clin North Am. 2013;44:451-62. https://doi.org/10.1016/j.ocl.2013.06.001 
  78. Muratoglu OK, Bragdon CR, O'Connor DO, Jasty M, Harris WH. A novel method of cross-linking ultra-high-molecular-weight polyethylene to improve wear, reduce oxidation, and retain mechanical properties. Recipient of the 1999 HAP Paul Award. J Arthroplasty. 2001;16:149-60. https://doi.org/10.1054/arth.2001.20540 
  79. Min BW, Lee KJ, Song KS, Bae KC, Cho CH. Highly crosslinked polyethylene in total hip arthroplasty for osteonecrosis of the femoral head: a minimum 5-year follow-up study. J Arthroplasty. 2013;28:526-30. https://doi.org/10.1016/j.arth.2012.07.010 
  80. Kim YH, Choi Y, Kim JS. Cementless total hip arthroplasty with alumina-on-highly cross-linked polyethylene bearing in young patients with femoral head osteonecrosis. J Arthroplasty. 2011;26:218-23. https://doi.org/10.1016/j.arth.2010.03.010 
  81. Youngman TR, Verhotz DR, Layon DR, et al. Mean 16-year results of total hip arthroplasty with alumina ceramic femoral heads on highly cross-linked polyethylene in patients 50 years or less. J Arthroplasty. Published online April 25, 2023; https://doi.org/10.1016/j.arth.2023.04.041 
  82. Bryan AJ, Calkins TE, Karas V, Culvern C, Nam D, Della Valle CJ. Primary total hip arthroplasty in patients less than 50 years of age at a mean of 16 years: highly crosslinked polyethylene significantly reduces the risk of revision. J Arthroplasty. 2019;34(7S):S238-41. https://doi.org/10.1016/j.arth.2019.02.025 
  83. Rames RD, Stambough JB, Pashos GE, Maloney WJ, Martell JM, Clohisy JC. Fifteen-year results of total hip arthroplasty with cobalt-chromium femoral heads on highly cross-linked polyethylene in patients 50 years and less. J Arthroplasty. 2019;34:1143-9. https://doi.org/10.1016/j.arth.2019.01.071 
  84. Koo KH, Ha YC, Jung WH, Kim SR, Yoo JJ, Kim HJ. Isolated fracture of the ceramic head after third-generation alumina-on-alumina total hip arthroplasty. J Bone Joint Surg Am. 2008;90:329-36. https://doi.org/10.2106/JBJS.F.01489 
  85. Lee YK, Ha YC, Yoo JI, Jo WL, Kim KC, Koo KH. Midterm results of the BIOLOX delta ceramic-on-ceramic total hip arthroplasty. Bone Joint J. 2017;99-B:741-8. https://doi.org/10.1302/0301-620X.99B6.BJJ-2016-0486.R3 
  86. Park YS, Park SJ, Lim SJ. Ten-year results after cementless THA with a sandwich-type alumina ceramic bearing. Orthopedics. 2010;33:796. https://doi.org/10.3928/01477447-20100924-11 
  87. Baek SH, Kim SY. Cementless total hip arthroplasty with alumina bearings in patients younger than fifty with femoral head osteonecrosis. J Bone Joint Surg Am. 2008;90:1314-20. https://doi.org/10.2106/JBJS.G.00755 
  88. Kang BJ, Ha YC, Ham DW, Hwang SC, Lee YK, Koo KH. Third-generation alumina-on-alumina total hip arthroplasty: 14 to 16-year follow-up study. J Arthroplasty. 2015;30:411-5. https://doi.org/10.1016/j.arth.2014.09.020 
  89. Park JW, Ko YS, Lee YK, Ha YC, Koo KH. Ten to 13-year results of delta ceramic-on-ceramic total hip arthroplasty in patients less than 30 years old. J Bone Joint Surg Am. 2023;105:789-96. https://doi.org/10.2106/JBJS.22.01291 
  90. Kim YH, Park JW, Jang YS, Kim EJ. Long-term results (minimum of 20 years) of a pure proximal-loading metaphyseal-fitting anatomic cementless stem without distal stem fixation in hip arthroplasty. J Arthroplasty. 2023;38:743-50. https://doi.org/10.1016/j.arth.2022.10.034 
  91. Konan S, Alazzawi S, Yoon BH, Cha YH, Koo KH. A focused update on preventing ceramic fractures in hip arthroplasty: is the 'cup' half full? Bone Joint J. 2019;101-B:897-901. https://doi.org/10.1302/0301-620X.101B8.BJJ-2019-0309.R1